These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36254020)

  • 1. Clinicopathological characteristics, survival outcomes and prognostic factors in the cT1N0M0 pancreatic neuroendocrine tumors: A SEER-based study.
    Guo N; Liang Z; Xiong LJ
    Medicine (Baltimore); 2022 Oct; 101(41):e31019. PubMed ID: 36254020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database.
    Sadula A; Li G; Xiu D; Ye C; Ren S; Guo X; Yuan C
    Comput Math Methods Med; 2022; 2022():3689895. PubMed ID: 35720036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors.
    Chen HY; Zhou YL; Chen YH; Wang X; Zhang H; Ke NW; Liu XB; Tan CL
    World J Gastroenterol; 2020 Jul; 26(25):3638-3649. PubMed ID: 32742132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).
    Martin-Perez E; Capdevila J; Castellano D; Jimenez-Fonseca P; Salazar R; Beguiristain-Gomez A; Alonso-Orduña V; Martinez Del Prado P; Villabona-Artero C; Diaz-Perez JA; Monleon A; Marazuela M; Pachon V; Sastre-Valera J; Sevilla I; Castaño A; Garcia-Carbonero R
    Neuroendocrinology; 2013; 98(2):156-68. PubMed ID: 23988576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic Contact Between T and N Classifications in Resected Well-Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms.
    Xu JZ; Wang WQ; Zhang SR; Xu HX; Wu CT; Qi ZH; Gao HL; Ni QX; Liu L; Yu XJ
    Ann Surg Oncol; 2018 Mar; 25(3):647-654. PubMed ID: 29235006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
    Chen J; Yang Y; Liu Y; Kan H
    World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes.
    Cheng Y; Zhan H; Wang L; Xu J; Zhang G; Zhang Z; Hu S
    Front Med; 2016 Dec; 10(4):444-450. PubMed ID: 27757796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival.
    Massironi S; Rossi RE; Zilli A; Casazza G; Ciafardini C; Conte D
    Oncotarget; 2016 Apr; 7(14):18978-83. PubMed ID: 26959887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Aggressive Behavior in Nonfunctional Pancreatic Neuroendocrine Tumors With Emphasis on Tumor Size Significance and Survival Trends: A Population-Based Analysis of 1787 Patients.
    Fathi AH; Romanyshyn J; Barati M; Choudhury U; Chen A; Sosa JA
    Am Surg; 2020 May; 86(5):458-466. PubMed ID: 32684030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis.
    Kurita Y; Hara K; Kuwahara T; Mizuno N; Okuno N; Haba S; Okuno M; Natsume S; Senda Y; Kubota K; Nakajima A; Niwa Y; Shimizu Y
    J Gastroenterol; 2020 May; 55(5):543-552. PubMed ID: 31858231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
    Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H
    Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study.
    Cai JS; Chen HY; Lu YF; Yu RS
    Future Oncol; 2020 Jan; 16(2):4369-4379. PubMed ID: 31802701
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
    Yao W; Wang W; Li G
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic neuroendocrine tumours: Grade is superior to T, N, or M status in predicting outcome and selecting patients for chemotherapy:A retrospective cohort study in the SEER database.
    Zhai H; Li D; Feng Q; Qian X; Li L; Yao J
    Int J Surg; 2019 Jun; 66():103-109. PubMed ID: 30872175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?
    Chivukula SV; Tierney JF; Hertl M; Poirier J; Keutgen XM
    Surgery; 2020 Jan; 167(1):180-186. PubMed ID: 31537303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms.
    Gao Y; Gao H; Wang G; Yin L; Xu W; Peng Y; Wu J; Jiang K; Miao Y
    Sci Rep; 2018 May; 8(1):7271. PubMed ID: 29739948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The number of positive lymph node is a better predictor of survival than the lymph node metastasis status for pancreatic neuroendocrine neoplasms: A retrospective cohort study.
    Zhang X; Lu L; Shang Y; Liu P; Wei Y; Ma L; Gong P
    Int J Surg; 2017 Dec; 48():142-148. PubMed ID: 29107188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study.
    Yang Z; Zhang D; Shi G
    Front Endocrinol (Lausanne); 2022; 13():928341. PubMed ID: 35923628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
    Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.
    Halfdanarson TR; Rabe KG; Rubin J; Petersen GM
    Ann Oncol; 2008 Oct; 19(10):1727-33. PubMed ID: 18515795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.